Polyarteritis nodosa is a rare multi-system disorder characterized by widespread inflammation, weakening, and damage to small and medium-sized arteries. Blood vessels in any organ or organ system may be affected, including those supplying the kidneys, heart, intestine, nervous system, and/or skeletal muscles.
ICD-10 code L95. 9 for Vasculitis limited to the skin, unspecified is a medical classification as listed by WHO under the range - Diseases of the skin and subcutaneous tissue .
ICD-10 code R68. 89 for Other general symptoms and signs is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
After diagnosis, patients are treated with high doses of corticosteroids. Other immunosuppressive drugs are also added for patients who are especially ill. In most cases of PAN now, if diagnosed early enough the disease can be controlled, and often cured.
“Angiitis” and “Arteritis” are both synonyms for vasculitis, literally meaning “inflammation within blood vessels” or “inflammation in arteries.” Because there are so many types of vasculitis, the group is sometimes referred to in the plural: vasculitides (pronounced “vas que lit' i deez”).
Systemic vasculitis is a general term referring to the inflammation of arteries and veins that progresses to necrosis, leading to a narrowing of the vessels. Although the specific cause of many of these disorders is not known, infectious organisms, drugs, tumors, and allergic reactions are some of the defined triggers.
R68. 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM R68.
89 - Other general symptoms and signs. ICD-10-CM.
Muscle weakness (generalized) The 2022 edition of ICD-10-CM M62. 81 became effective on October 1, 2021. This is the American ICD-10-CM version of M62. 81 - other international versions of ICD-10 M62.
Morbidity and mortality — Untreated polyarteritis nodosa (PAN) is associated with a poor prognosis (13 percent five-year survival) [5,6]. The outcome of PAN has improved in patients receiving treatment; five-year survival is approximately 80 percent [7].
Prognosis for PAN Without treatment, people with polyarteritis nodosa have a less than 15% chance of surviving 5 years. With treatment, people with polyarteritis nodosa have a greater than 80% chance of surviving 5 years. People whose kidneys, digestive tract, brain, or nerves are affected have a poor prognosis.
PAN is not a form of cancer, it is not contagious, and it does not usually occur within families. Evidence from research laboratories strongly supports that the immune system plays a critical role in PAN, causing blood vessel and tissue inflammation and damage.
09: Other abnormal glucose.
A nutritional condition produced by a deficiency of vitamin d in the diet, insufficient production of vitamin d in the skin, inadequate absorption of vitamin d from the diet, or abnormal conversion of vitamin d to its bioactive metabolites.
005009: Complete Blood Count (CBC) With Differential | Labcorp.
ICD-10 code: R94. 6 Abnormal results of thyroid function studies.